利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

8 条记录 (耗时 0.028 秒)

    Arylaminomethylenecamphor derivatives
    4.
    发明授权
    Arylaminomethylenecamphor derivatives 失效
    芳基亚甲基am卟啉衍生物

    公开(公告)号：US5932195A

    公开(公告)日：1999-08-03

    申请号：US6175

    申请日：1998-01-13

    申请人： Michael Drogemuller ,  Volker Bomm ,  Volker Schehlmann ,  Horst Westenfelder

    发明人： Michael Drogemuller ,  Volker Bomm ,  Volker Schehlmann ,  Horst Westenfelder

    IPC分类号： C07D215/42 ,  A61K8/00 ,  A61Q17/04 ,  C07C225/14 ,  C07C229/54 ,  C07C237/30 ,  C07C309/46 ,  C07C311/39 ,  C09K3/00 ,  A61K7/42 ,  A61K7/44 ,  C07C229/56

    CPC分类号： C07C225/14 ,  C07C2102/42

    摘要： Arylaminomethylenecamphor derivatives of the formula (1) ##STR1## where the C.dbd.C double bond is in the Z or E configuration, and the variables have the following meanings:R.sup.1 H, CH.sub.3,R.sup.2 H, C.sub.1 -C.sub.6 -alkyl, C.sub.3 -C.sub.8 -cycloalkyl, C.sub.2 -C.sub.6 -alkenyl, C.sub.3 -C.sub.8 -cycloalkenyl, aryl or substituted aryl,R.sup.3 H, C.sub.1 -C.sub.6 -alkyl, C.sub.3 -C.sub.8 -cycloalkyl, aryl, substituted aryl, C.sub.1 -C.sub.6 -alkoxy, C.sub.1 -C.sub.8 -acyl,Ar aryl, substituted aryl, hetaryl or substituted hetaryl,are used as sunscreen agents, especially in cosmetic and pharmaceutical formulations.

    摘要翻译： 其中C = C双键为Z或E构型的式（1）的芳基亚氨基亚甲基am卟啉衍生物，并且变量具有以下含义：R 1 H，CH 3，R 2 H，C 1 -C 6烷基，C 3 -C 8 - 环烷基 ，C 2 -C 6 - 烯基，C 3 -C 8 - 环烯基，芳基或取代的芳基，R 3 H，C 1 -C 6 - 烷基，C 3 -C 8 - 环烷基，芳基，取代的芳基，C 1 -C 6 - 烷氧基，C 1 -C 8酰基， Ar芳基，取代芳基，杂芳基或取代的杂芳基用作防晒剂，特别是在化妆品和药物制剂中。

    Selective reduction of alkyne compounds
    6.
    发明授权
    Selective reduction of alkyne compounds 失效
    选择性还原炔化合物

    公开(公告)号：US06590111B2

    公开(公告)日：2003-07-08

    申请号：US10217488

    申请日：2002-08-14

    申请人： Johannes Grimmer ,  Thomas Müller ,  Volker Bomm

    发明人： Johannes Grimmer ,  Thomas Müller ,  Volker Bomm

    IPC分类号： C07D31744

    CPC分类号： C07C403/08 ,  C07C2601/16 ,  C07D317/64 ,  Y02P20/55

    摘要： A process is provided for the preparation of cyclohexene derivatives of general formula I or II: in which the substituents R1 and R2 independently of one another are defined as follows: R2 is OH or a protective group convertible to a hydroxyl group by hydrolysis, R3 and R4 are hydrogen or C1-C4-alkyl, and R5 is hydrogen or C1-C4-acyl, by the reduction or alkyne compounds of general formula III or IV: wherein the reducing agent used is at least one salt of hyposulfurous acid or hydroxymethanesulfinic acid or a mixture of at least one salt of hyposulfurous acid and at least one salt of hydroxymethanesulfinic acid.

    摘要翻译： 提供用于制备通式I或II的环己烯衍生物的方法：其中取代基R 1和R 2彼此独立地定义如下：R 2是OH或通过水解可转化成羟基的保护基，R3和 R 4是氢或C 1 -C 4烷基，R 5是氢或C 1 -C 4酰基，通过通式III或IV的还原或炔化合物：其中所用的还原剂是至少一种次亚硫酸或羟基甲烷亚磺酸的盐或 至少一种次亚硫酸的盐与至少一种羟基甲烷亚磺酸的盐的混合物。

    Cosmetic and pharmaceutical preparations containing photostable UV filters
    7.
    发明授权
    Cosmetic and pharmaceutical preparations containing photostable UV filters 有权
    含有光稳定紫外线过滤器的化妆品和药物制剂

    公开(公告)号：US06545174B2

    公开(公告)日：2003-04-08

    申请号：US09765624

    申请日：2001-01-22

    申请人： Thorsten Habeck ,  Sylke Haremza ,  Volker Schehlmann ,  Horst Westenfelder ,  Thomas Wünsch ,  Michael Drögemüller ,  Volker Bomm

    发明人： Thorsten Habeck ,  Sylke Haremza ,  Volker Schehlmann ,  Horst Westenfelder ,  Thomas Wünsch ,  Michael Drögemüller ,  Volker Bomm

    IPC分类号： C07C6976

    CPC分类号： C07C235/34 ,  A61K8/35 ,  A61K8/37 ,  A61K8/40 ,  A61K8/42 ,  A61K31/12 ,  A61K31/122 ,  A61K31/216 ,  A61K31/277 ,  A61K2800/52 ,  A61Q1/04 ,  A61Q17/04 ,  C07C69/618 ,  C07C233/11

    摘要： 4,4-Diarylbutadienes of the formula I, where the diene system has the Z,Z; Z,E; E,Z or E,E configuration or a mixture thereof, and where the variables independently of one another have the following meanings: R1 and R2 are hydrogen, C1-C20-alkyl, C2-C10-alkenyl, C3-C10-cycloalkyl, C3-C10-cycloalkenyl, C1-C12-alkoxy, C1-C20-alkoxycarbonyl, C1-C12-alkylamino, C1-C12-dialkylamino, aryl, hetaryl, unsubstituted or substituted, substituents which confer solubility in water and are selected from the group consisting of carboxylate, sulfonate, or ammonium residues; R3 is COOR5, CONR5R6; R4 is COOR6, CONR5R6; R5 and R6 are hydrogen, C1-C20-alkyl, C2-C10-alkenyl, C3-C10-cycloalkyl, C7-C10-bicycloalkyl, C3-C10-cycloalkenyl, C7-C10-bicycloalkenyl, aryl, hetaryl, unsubstituted or substituted; n is 1 to 3; and R3 and R4 are not COOCH3 when R1 and R2 are hydrogen, are used as photostable UV filters in cosmetic and pharmaceutical preparations to protect the human skin or human hair from the sun's rays, alone or together with compounds which absorb in the UV region and are known per se for cosmetic and pharmaceutical preparations.

    摘要翻译： 式I的4,4-二芳基丁二烯，其中二烯体系具有Z，Z; Z，E; E，Z或E，E构型或其混合物，其中彼此独立的变量具有以下含义：R 1和R 2为氢，C 1 -C 20 - 烷基，C 2 -C 10 - 烯基，C 3 -C 10 - 环烷基， C 3 -C 10 - 环烯基，C 1 -C 12 - 烷氧基，C 1 -C 20烷氧基羰基，C 1 -C 12 - 烷基氨基，C 1 -C 12 - 二烷基氨基，芳基，杂芳基，未取代或取代的取代基，其赋予在水中的溶解性并且选自 由羧酸盐，磺酸盐或铵残基组成; R3为COOR5，CONR5R6; R4是COOR6，CONR5R6; R 5和R 6是氢，C 1 -C 20烷基，C 2 -C 10 - 烯基，C 3 -C 10 - 环烷基，C 7 -C 10 - 双环烷基，C 3 -C 10 - 环烯基，C 7 -C 10 - 双环烯基，芳基，杂芳基，未取代或取代的; n为1〜3; 当R 1和R 2为氢时，R 3和R 4不是COOCH 3，用作化妆品和药物制剂中的光稳定性UV过滤剂，以保护人皮肤或人类头发免受太阳光线的影响，单独或与在UV区域吸收的化合物一起， 本身就是化妆品和药物制剂。